15 results
Chart of Inhalers for Asthma and COPD
 - SABA - Short Acting Beta-2 Agonists
 - SAMA
- SABA - Short ... -2 Agonists - LAMA ... - ICS + LAMA + ... - ICS - Inhaled ... #respiratory #pharmacology
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
COPD Preferred Treatments ... Management of COPD ... that include LABA ... LAMA/LABA/ICS. ... #Treatment #Management
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
#COPD #Treatment ... #Algorithm #Management ... #Pulmonary #LABA ... #LAMA #SABA #SAMA ... #ICS #Pharmacology
Long-Acting Dual Bronchodilators - LAMA/LABA Combo Inhalers 

The FDA approved a new dual bronchodilator (LABA/LAMA) combination
/LABA Combo Inhalers ... bronchodilator (LABA ... is approved for treatment ... #LABA #Combo #Inhalers ... #Combination #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... LAMA: long-acting ... : inhaled corticosteroid ... #Management #Pulmonary ... #LAMA #LABA #ICS
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
/LABA or Med/High ... dose ICS/LABA ... /LABA -> High ... dose ICS/LABA + ... #Pharmacology #
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... Beta2 Agonists (LABA ... Here are the LABA ... These combo LABA ... for the COPD treatment
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
inhaled corticosteroids ... ; LABA = long-acting ... β2-agonist; LAMA ... #Diagnosis #Management ... #ACOPD #Asthma
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... ICS: inhaled corticosteroids ... ; SABA: short-acting ... receptor antagonists; LABA ... #GINA #Asthma #Management
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Triple Therapy (LAMA ... /LABA/ICS) - ... Bronchodilators (LAMA ... /LABA) & Eosinophils ... #Indications #Pharmacology